The FDA’s final guidance on Predetermined Change Control Plans allows manufacturers of AI-enabled medical devices to implement specified post-market changes without additional authorizations, emphasizing the importance of rigorous documentation and compliance to ensure safety and effectiveness.
View full story…
FDA Issues Final Guidance on Predetermined Change Control Plans for AI-Enabled Medical Devices
